GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China Meheco Group Co Ltd (SHSE:600056) » Definitions » 14-Day RSI

China Meheco Group Co (SHSE:600056) 14-Day RSI : 60.11 (As of Dec. 12, 2024)


View and export this data going back to 1997. Start your Free Trial

What is China Meheco Group Co 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-12-12), China Meheco Group Co's 14-Day RSI is 60.11.

The industry rank for China Meheco Group Co's 14-Day RSI or its related term are showing as below:

SHSE:600056's 14-Day RSI is ranked worse than
66.09% of 115 companies
in the Medical Distribution industry
Industry Median: 49.24 vs SHSE:600056: 60.11

Competitive Comparison of China Meheco Group Co's 14-Day RSI

For the Medical Distribution subindustry, China Meheco Group Co's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Meheco Group Co's 14-Day RSI Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China Meheco Group Co's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where China Meheco Group Co's 14-Day RSI falls into.



China Meheco Group Co  (SHSE:600056) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Meheco Group Co  (SHSE:600056) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


China Meheco Group Co 14-Day RSI Related Terms

Thank you for viewing the detailed overview of China Meheco Group Co's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


China Meheco Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Xiying Street, Floor 18-28, Block B, Building 1, General Times Center, District 1, Fengtai, Beijing, CHN, 100073
China Meheco Group Co Ltd is engaged in the distribution and trading of botanical medicines, medical instruments, and pharmaceuticals. It offers botanic medicines and herbal products, as well as exports of natural medicines, including herbs, spices, plant extracts, bee products, and Chinese traditional medicines. The company's business scope covers the whole industry chain, from research and development, cultivation and processing, manufacturing, distribution, and logistics to international trading, academic promotion, and technical service. The corporation provides trading services for customers in the pharmaceutical and chemical field, covering APIs, preparations, biologicals, blood products, and others.
Executives
Qi Jian Xi senior management
Ni Xiao Ling Director

China Meheco Group Co Headlines

No Headlines